This study aims to fill the knowledge gap by investigating the predictors of success for TPVB in patients with herpetic neuralgia. By identifying demographic, clinical, previous medications and procedural factors associated with positive outcomes, this research seeks to enhance the efficacy of TPVB and improve pain management strategies for patients suffering from herpetic neuralgia.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adults aged from18 to 70 years
* Diagnosed with herpetic neuralgia.
* Able and willing to provide informed consent.
* ASA I - II
* One dermatomal affection
* Thoracic distribution
Exclusion Criteria:
* Contraindications to TPVB as ( Infection at site of injection, empyema , …
Inclusion Criteria:
* Adults aged from18 to 70 years
* Diagnosed with herpetic neuralgia.
* Able and willing to provide informed consent.
* ASA I - II
* One dermatomal affection
* Thoracic distribution
Exclusion Criteria:
* Contraindications to TPVB as ( Infection at site of injection, empyema , coagulopathy and neoplastic lesion occupying the paravertebral space)
* Known allergies to study medications (bupivacaine, Dexamethasone).
* Severe comorbidities that could interfere with study participation.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.